CNS atypical T-cell lymphoproliferative disease following treatment with alemtuzumab

Murtaza Khan, Douglas E. Ney, Bette K. Kleinschmidt-DeMasters, Lindsay Horton, Enrique Alvarez, Amanda L. Piquet

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'CNS atypical T-cell lymphoproliferative disease following treatment with alemtuzumab'. Together they form a unique fingerprint.